{"id":"W7108440548","doi":"10.1182/blood-2025-1240","title":"Favorable safety and therapeutic efficacy of a novel humanized anti-ADAMTS13 antibody in acquired von willebrand syndrome: A preclinical study","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Aging","funders":"","keywords":"Von Willebrand factor; Antibody; Tolerability; In vivo; Von Willebrand disease; Therapeutic effect; Toxicity; Humanized antibody; Safety pharmacology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070952,0.0009655839,0.0007957015,0.000513623,0.0002673003,0.0004126862,0.0005148484,0.0005790215,0.001700526],"category_scores_gemma":[0.0002420101,0.0002144213,0.0005882232,0.0002298808,0.0004978527,0.0005715793,0.0001532665,0.001487546,0.0004301819],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003724133,"about_ca_system_score_gemma":0.0005439879,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000644486,"about_ca_topic_score_gemma":0.0007727697,"domain_scores_codex":[0.9997635,0.00005755817,0.00001737391,0.00005049902,0.00004582653,0.0000650567],"domain_scores_gemma":[0.9997467,0.00002759176,0.00005374395,0.00003223098,0.00003966604,0.00009999972],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00629742,0.01371548,0.0006261324,0.0003639865,0.000162314,0.0002526949,0.00008937014,0.0004363117,0.9595885,0.0002650597,0.0008029126,0.01739988],"study_design_scores_gemma":[0.004789297,0.3439074,0.007628503,0.00004761278,0.0007272559,0.001207747,0.00008571691,0.002753225,0.6295584,0.0002375446,0.00901983,0.00003752519],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9920868,0.003181025,0.002518688,0.0002203582,0.0001402648,0.0003924012,0.0004549163,0.00008327988,0.0009222222],"genre_scores_gemma":[0.9906694,0.003257011,0.002118221,0.0001626137,0.0001184501,0.0003614867,0.0009365037,0.00001652596,0.002359769],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001700526,"threshold_uncertainty_score":0.005688787,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02252423732850881,"score_gpt":0.3315419361617272,"score_spread":0.3090176988332184,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}